A Prospective and Partially Retrospective Study to Characterize Safety and Efficacy of Allogeneic HSCT for the Treatment of Childhood Cerebral Adrenoleukodystrophy
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Bluebird Bio
Start Date
September 1, 2015
End Date
March 31, 2021
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Bluebird Bio
Start Date
September 1, 2015
End Date
March 31, 2021